Dr. Candace Westgate discusses the latest advancements in precision medicine and multi-cancer early detection (MCED) blood tests. This session will explain how these groundbreaking tests work, who may benefit from them, and what to consider when integrating them into a personal prevention plan. With the ability to detect dozens of cancers before symptoms arise, MCED testing represents a new frontier in proactive, individualized healthcare.
The session will begin with a 30-minute overview from Dr. Westgate, followed by a 30-minute live Q&A moderated by Dr. Lisa Larkin. Dr. Westgate will answer audience questions and address common concerns about MCED testing, cancer risk assessment, and the role of precision medicine in women’s health.
Candace Westgate, DO, MPH, FACOG, NCMP is a board-certified Obstetrician-Gynecologist with specialized expertise in cancer risk assessment, menopause care, and personalized preventive medicine. She earned her Master of Public Health from Tulane University, focusing on maternal and child health, and completed her medical degree at Kirksville College of Osteopathic Medicine. Her OBGYN residency training was completed at Georgetown University Hospital in Washington, D.C.
Dr. Westgate holds advanced certifications in Advanced Laparoscopy, Menopause Management (NCMP), and Genomic Counseling through ACOG. She is also a 2018 graduate of the City of Hope’s Intensive Course in Genomic Cancer Risk Assessment. Her approach to care is rooted in precision medicine—integrating genetic, lifestyle, and hormonal factors to deliver individualized, evidence-based solutions for women across the lifespan.
She is the founder of the AHEAD Program, a population-based initiative focused on cancer risk assessment, prevention, and early detection at Adventist Health in California. She now serves as the Director of Personalized Medicine at Community Health Network in Indianapolis, Indiana, where she continues to lead efforts to integrate genomics and preventive strategies into clinical practice.
A respected educator and advocate, Dr. Westgate is passionate about making complex science accessible to patients and providers alike. She regularly speaks at public and professional forums on topics including early cancer detection, cancer risk assessment and genetic testing, and innovations in personalized prevention.
Dr. Lisa Larkin, MD, FACP, MSCP, IF, will moderate the discussion, bringing her expertise in women’s health and prevention to the conversation. As a certified menopause practitioner and founder of HERmedicine and Ms.Medicine, Dr. Larkin is dedicated to advancing evidence-based care and helping women make informed choices about their health at every stage of life.